Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines - PubMed (original) (raw)
. 1994 Sep 15;54(18):4988-92.
Affiliations
- PMID: 8069866
Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines
Y Sekido et al. Cancer Res. 1994.
Abstract
Small cell lung cancer (SCLC) is known to express the HuD protein, the neuronal antigen homologous to Drosophila Elav and Sxl genes involved in neuronal and sex development. HuD is the target of an immune response including high titered antibodies causing paraneoplastic encephalomyelitis and sensory neuropathy. Because the p53 recessive oncogene is mutated and anti-p53 antibodies frequently occur in cancer patients, we wondered if the development of anti-HuD antibodies signaled the presence of HuD mutations in lung cancer. The HuD gene was mapped to chromosome region 1p using a human-mouse hybrid cell panel. We confirmed that 26 of 46 cancer (43 lung cancer and 3 mesothelioma) cell lines expressed HuD mRNA and that this expression, as well as protein expression by Western blot, correlated strongly with the SCLC neuroendocrine phenotype. Southern blot and single-strand conformation polymorphism analyses showed that HuD was not mutated in 78 lung cancers, including patients with the severe paraneoplastic syndrome. Northern blot analysis showed that lung cancer cell lines expressed two major mRNAs (4.3 and 4.0 kilobases) of HuD. We found the three previously described alternative spliced mRNA forms (HuDpro, HuD, and HuDmex). In addition, we also found HuD mRNA had an alternative splicing form in its 5'-coding region. This alternative splice introduced 87 base pairs of sequence and a termination codon resulting in a predicted small, truncated protein (11 amino acids) reminiscent of the male-specific truncated protein in the Sex-lethal (Sxl) gene of Drosophila. However, mRNAs encoding both full-length and truncated proteins were expressed in all SCLCs. These results show that the HuD gene is not mutated in lung cancer, including tumors from patients producing anti-HuD antibodies, but HuD expression is an independent marker or determinant of the neuroendocrine differentiation seen in SCLC.
Similar articles
- Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.
Manley GT, Smitt PS, Dalmau J, Posner JB. Manley GT, et al. Ann Neurol. 1995 Jul;38(1):102-10. doi: 10.1002/ana.410380117. Ann Neurol. 1995. PMID: 7541976 - Expression of HuD (a paraneoplastic encephalomyelitis antigen) mRNA in lung cancer.
Cho JH, Noguchi M. Cho JH, et al. J Korean Med Sci. 1997 Aug;12(4):305-10. doi: 10.3346/jkms.1997.12.4.305. J Korean Med Sci. 1997. PMID: 9288629 Free PMC article. Clinical Trial. - Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
Cairns P, Okami K, King P, Bonacum J, Ahrendt S, Wu L, Mao L, Jen J, Sidransky D. Cairns P, et al. Cancer Res. 1997 Dec 1;57(23):5356-9. Cancer Res. 1997. PMID: 9393760 - Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer.
Minna JD, Battey JF, Birrer M, Brooks BJ, Cuttitta F, DeGreve J, Gazdar AF, Johnson BE, Nau MM, Sausville EA, et al. Minna JD, et al. Princess Takamatsu Symp. 1986;17:109-22. Princess Takamatsu Symp. 1986. PMID: 3332004 Review. - [Recent advances in paraneoplastic encephalomyeloneuronopathy].
Sakai K. Sakai K. Nihon Rinsho. 1994 Nov;52(11):3006-12. Nihon Rinsho. 1994. PMID: 7996702 Review. Japanese.
Cited by
- Autoimmunity in paraneoplastic neurological syndromes.
Giometto B, Taraloto B, Graus F. Giometto B, et al. Brain Pathol. 1999 Apr;9(2):261-73. doi: 10.1111/j.1750-3639.1999.tb00225.x. Brain Pathol. 1999. PMID: 10219744 Free PMC article. Review. - Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression.
Antic D, Keene JD. Antic D, et al. Am J Hum Genet. 1997 Aug;61(2):273-8. doi: 10.1086/514866. Am J Hum Genet. 1997. PMID: 9311730 Free PMC article. Review. No abstract available. - Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.
Kazarian M, Laird-Offringa IA. Kazarian M, et al. Mol Cancer. 2011 Mar 30;10:33. doi: 10.1186/1476-4598-10-33. Mol Cancer. 2011. PMID: 21450098 Free PMC article. Review. - Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients.
Usami N, Fukui T, Kondo M, Taniguchi T, Yokoyama T, Mori S, Yokoi K, Horio Y, Shimokata K, Sekido Y, Hida T. Usami N, et al. Cancer Sci. 2006 May;97(5):387-94. doi: 10.1111/j.1349-7006.2006.00184.x. Cancer Sci. 2006. PMID: 16630136 Free PMC article. - Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells.
Hamid AB, Petreaca RC. Hamid AB, et al. Cancers (Basel). 2020 Apr 9;12(4):927. doi: 10.3390/cancers12040927. Cancers (Basel). 2020. PMID: 32283832 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous